InvestorsObserver is giving Syndax Pharmaceuticals Inc (SNDX) an Analyst Rating Rank of 60, meaning SNDX is ranked higher by analysts than 60% of stocks. The average price target for SNDX is $27.75 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating SNDX a Strong Buy today. Find out what this means to you and get the rest of the rankings on SNDX!
Why are Analyst Ratings Important?
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Syndax Pharmaceuticals Inc Stock Today?
Syndax Pharmaceuticals Inc (SNDX) stock is higher by 2.02% while the S&P 500 has fallen -0.66% as of 11:37 AM on Friday, Sep 17. SNDX has gained $0.39 from the previous closing price of $19.31 on volume of 273,686 shares. Over the past year the S&P 500 has gained 32.39% while SNDX has gained 15.47%. SNDX lost -$1.89 per share the over the last 12 months.
Click Here to get the full Stock Report for Syndax Pharmaceuticals Inc stock.